Sariah Liu is an Oncology physician. OpenAlex indexes 10 publications with 380 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
361 Old Belgrade Rd
Augusta, ME 043308058
Telephone
207-621-6100Provider last certified this registry record 29 Feb 2024.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
52.3%Aromatase Inhibitor17.3%Anastrozole81%Letrozole19%Part D<11 patientsCytochrome P450 17A1 Inhibitor16%Abiraterone Acetate100%Part D≥16 patients+ 5 more classes in this area
Blood & clotting
14%Factor Xa inhibitor11.9%Eliquis83%Xarelto17%Part D<11 patientsLow Molecular Weight Heparin2.2%Enoxaparin Sodium100%Part D<11 patientsMetabolism & gastrointestinal
13.7%Corticosteroid9%Prednisone100%Part D≥14 patientsSerotonin-3 Receptor Antagonist2.7%Ondansetron Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine
Journal of Clinical Medicine
2023 - Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach
Journal of Clinical Medicine
2020 - Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care
Journal of Clinical Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”